Literature DB >> 2606800

Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment.

A M Brown1, B McDowell, A Forge.   

Abstract

Acoustic distortion has been measured from the ear canals of guinea pigs treated with the aminoglycoside antibiotic gentamicin. The correlation between pre- and post-treatment levels of distortion can be related to the extent of outer hair cell (OHC) pathology induced by gentamicin. All animals that were treated and show functional changes also show changes in OHC morphology. Changes in distortion properties are evident before clear changes in surface hair cell morphology are seen. In the early stages of intoxication, thin sections of the organ of Corti are necessary to reveal the underlying structural changes accompanying functional impairment. Where OHCs have been affected by gentamicin treatment, the greatest change in 2f1-f2 level is for distortion generated by widely spaced stimuli. With closely spaced stimuli, 2f1-f2 may be unchanged in level, but higher order distortion components are depressed. Functional evidence of mild OHC disruption is only revealed by stimulus levels at or below 60 dB SPL. With higher sound levels, apparently normal levels of distortion can be generated by ears in which there is clear evidence of OHC pathology. In a single, untreated animal with an extensive basal turn lesion, some 2f1-f2 distortion was generated when the stimulus frequency region lacked OHCs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606800     DOI: 10.1016/0378-5955(89)90140-8

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  20 in total

1.  High-frequency two-tone distortions from the ear of the mustached bat, Pteronotus parnellii reflect enhanced cochlear tuning.

Authors:  M Kössl
Journal:  Naturwissenschaften       Date:  1992-09

2.  Is there a close relationship between changes in amplitudes of distortion product otoacoustic emissions and hair cell damage after exposure to realistic industrial noise in guinea pigs?

Authors:  V Linss; E Emmerich; F Richter; W Linss
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-09       Impact factor: 2.503

3.  Prospective noise induced changes to hearing among construction industry apprentices.

Authors:  N S Seixas; B Goldman; L Sheppard; R Neitzel; S Norton; S G Kujawa
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

4.  The cochleogram of the guinea pig.

Authors:  Volker Linss; Werner Linss; Edeltraut Emmerich; Frank Richter
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-03       Impact factor: 2.503

5.  Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer.

Authors:  Süleyman Yilmaz; Fatih Oktem; Emin Karaman
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-28       Impact factor: 2.503

6.  The efferent-mediated suppression of otoacoustic emissions in awake guinea pigs and its reversible blockage by gentamicin.

Authors:  P Avan; J P Erre; D L da Costa; J M Aran; J Popelár
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

7.  Digital music exposure reliably induces temporary threshold shift in normal-hearing human subjects.

Authors:  Colleen G Le Prell; Shawna Dell; Brittany Hensley; James W Hall; Kathleen C M Campbell; Patrick J Antonelli; Glenn E Green; James M Miller; Kenneth Guire
Journal:  Ear Hear       Date:  2012 Nov-Dec       Impact factor: 3.570

8.  Effects of salicylates and aminoglycosides on spontaneous otoacoustic emissions in the Tokay gecko.

Authors:  C E Stewart; A J Hudspeth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 9.  Otoacoustic emissions: a new method to diagnose hearing impairment in children.

Authors:  P G Zorowka
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

10.  On a possible prognostic value of otoacoustic emissions: a study on patients with sudden hearing loss.

Authors:  Sebastian Hoth
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-05       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.